UK markets open in 35 minutes
NIKKEI 225
28,546.98 +727.65 (+2.62%) HANG SENG
20,177.59 +95.16 (+0.47%) CRUDE OIL
93.95 -0.39 (-0.41%) GOLD FUTURES
1,806.70 -0.50 (-0.03%) DOW
33,336.67 +27.16 (+0.08%) BTC-GBP
19,644.50 -588.09 (-2.91%)
NVAX Sep 2022 90.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:31AM EDT. Market open.
| Previous close | 46.71 |
| Open | 46.77 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 90.00 |
| Expiry date | 2022-09-16 |
| Day's range | 46.71 - 46.81 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Simply Wall St.
These Analysts Just Made An Downgrade To Their Novavax, Inc. (NASDAQ:NVAX) EPS Forecasts
The latest analyst coverage could presage a bad day for Novavax, Inc. ( NASDAQ:NVAX ), with the analysts making...
- Zacks
Epizyme (EPZM) Q2 Earnings Beat Estimates, Revenues Up Y/Y
Epizyme (EPZM) posts a narrower-than-expected loss in the second quarter. Revenues beat estimates.
- Motley Fool
1 Reason to Sell Novavax Stock, and 1 Reason to Buy
This year hasn't been an easy one for Novavax (NASDAQ: NVAX) investors. After a series of stumbles culminating in its disastrous earnings report on Aug. 8, its shares are down by 60% so far in 2022. And with management slashing its full-year revenue guidance by roughly half, there isn't much hope for smoother sailing for at least a few quarters.
© 2022 Yahoo. All rights reserved.
